riding the nanotechnology wave - oxford instruments · pdf fileriding the nanotechnology wave...
TRANSCRIPT
The Business of Science®
Page 1 © Oxford Instruments 2013
Riding the
Nanotechnology Wave
13th February 2013
The Business of Science®
Page 2 © Oxford Instruments 2013
• General concepts, Nanotechnology and Tools – Jonathan Flint, Chief Executive
• Applying concepts to markets – Andy Matthews, Group Operations Director
• Accessing markets – Kevin Boyd, Group Finance Director
• Managing products and people – Ian Barkshire, Group Technical Director
• Summary and conclusions – Jonathan Flint, Chief Executive
Agenda
Page 3 © Oxford Instruments 2013
The Business of Science®
• Mathematics
This presentation may contain Science
Page 4 © Oxford Instruments 2013
The Business of Science®
• Mathematics
• Physics
This presentation may contain Science
Page 5 © Oxford Instruments 2013
The Business of Science®
• Mathematics
• Physics
• Chemistry
This presentation may contain Science
Page 6 © Oxford Instruments 2013
The Business of Science®
• Mathematics
• Physics
• Chemistry
• Quantum Mechanics
This presentation may contain Science
The Business of Science®
Page 9 © Oxford Instruments 2013
Nanotechnology is a
mathematical certainty
The Business of Science®
Page 10 © Oxford Instruments 2013
• Surface area really matters
– Same volume of material
– 1 nm Nanoparticles have 10 million times the surface
area of a 1cm cube
Chemistry
Image courtesy of www.nano.gov/naonotech-101
The Business of Science®
Page 11 © Oxford Instruments 2013
Basic chemistry makes
Nanotechnology
inevitable
The Business of Science®
Page 17 © Oxford Instruments 2013
• Quantum Encryption
• Quantum Computing
The Quantum leap to Nanotechnology
The Business of Science®
Page 19 © Oxford Instruments 2013
Scientific principles make
Nanotechnology inevitable
Page 20 © Oxford Instruments 2013
The Business of Science®
How can you harvest
near term and long
term value from
Nanotechnology?
Page 25 © Oxford Instruments 2013
The Business of Science®
Nanotechnology Tools
• NanoAnalysis Asylum Research Omniprobe
• NanoScience
• Omicron
• Plasma Technology
Industrial Products
• Industrial Analysis X-ray Fluorescence Optical Emission Spectroscopy Magnetic Resonance
• Industrial
Components Austin Superconducting Wire X-ray Technology
Service
• OiService CT& MR (3rd Party)
• NT & IP Service (OI products)
Our Businesses
The Business of Science®
Page 29 © Oxford Instruments 2013
• High Tech Healthcare
Global Trends
0
500
1000
1500
2000
2500
2000 2010 2020 2030 2040 2050
Mill
ions
Year
World Population 60 and Over: 2000 - 2050
Source: Ageing societies – Sarah Harper (Hodder Arnold)
The Business of Science®
Page 30 © Oxford Instruments 2013
• Emerging markets
Global Trends
0
10
20
30
40
50
60
2010 2050
Constant 2000 USD, Tn
Growth of Emerging Markets vs Developing Markets
Developed Markets Emerging Markets
Source HSBC Calculations
The Business of Science®
Page 31 © Oxford Instruments 2013
• New Materials
• Environment
• New sources of energy
• High Tech Healthcare
• Emerging Markets
Company of the Future
The Business of Science®
Page 33 © Oxford Instruments 2013
Oxford Instruments
• Market:
• Model:
• Products:
Nanotechnology
Tools
Driven by Global Trends
The Business of Science®
Page 34 © Oxford Instruments 2013
Applying Concepts to Markets
Andy Matthews
Group Operations Director
The Business of Science®
Page 35 © Oxford Instruments 2013
Convergence of sciences
The Nanotechnology Revolution
Nano science
Nanotechnology
Bio Chem Phys
The Business of Science®
Page 36 © Oxford Instruments 2013
Convergence of sciences
The Nanotechnology Revolution
Nano science
Nanotechnology
Bio Chem Phys
Repeatable
Fabrication & Measurement
capability
The Business of Science®
Page 37 © Oxford Instruments 2013
Global Markets
Convergence of sciences
The Nanotechnology Revolution
Bio Chem Phys
Repeatable
Fabrication & Measurement
capability
Nanotechnology
Nano science
Auto & Aviation
Metals Consumer Chemicals
Semi-con Pharma/
health
The Business of Science®
Page 39 © Oxford Instruments 2013
Nanotechnology Markets
Nanotechnology Enabled
Products
The Business of Science®
Page 40 © Oxford Instruments 2013
Nanotechnology Markets
Nanotechnology Enabled Products
Growing at 30%-40% CAGR
The Business of Science®
Page 41 © Oxford Instruments 2013
The Nanotechnology Revolution
Global Markets
Consumer
Semi-con
The Business of Science®
Page 42 © Oxford Instruments 2013
The Nanotechnology Revolution
Global Markets
Pharma/ health
The Business of Science®
Page 43 © Oxford Instruments 2013
The Nanotechnology Revolution
Global Markets
Auto & Aviation
Metals Chemicals
The Business of Science®
Page 44 © Oxford Instruments 2013
Global Markets
Convergence of sciences
The Nanotechnology Revolution
Bio Chem Phys
Repeatable
Fabrication & Measurement
capability
Nanotechnology
Nano science
Auto & Aviation
Metals Consumer Chemicals
Semi-con Pharma/
health
The Business of Science®
Page 45 © Oxford Instruments 2013
Governments’ funding of
Nanotechnology
Source: Cientifica ltd. 2011
20% growth in funding in next 3 years
The Business of Science®
Page 46 © Oxford Instruments 2013
US Government Nanotechnology Funding
Source: NNI (Nano.Gov Web Site)
The Business of Science®
Page 47 © Oxford Instruments 2013
Nanotechnology Market
• Nanotechnology market = $17 billion
• Growing at 10% -15% CAGR
• Nanotools market = $4 billion
The Business of Science®
Page 48 © Oxford Instruments 2013
• Nanotechnology enabled product – High efficiency solar cells currently in development
• Nanotechnology – Thin film 10nm Al2O3 layer used to improve efficiency
• Nanotool – FlexAl ALD tool from Plasma Technology
Nanotechnology Example
The Business of Science®
Page 49 © Oxford Instruments 2013
World Nanotechnology Market
World GDP ≈ $70 trillion
World Industry GDP ≈ $22 trillion Nano-enabled products ≈ $1 trillion
Nano products ≈ $17 billion
NanoTools ≈ $4 billion
The Business of Science®
Page 50 © Oxford Instruments 2013
Accessing markets
Kevin Boyd
Group Finance Director
The Business of Science®
Page 51 © Oxford Instruments 2013
World Nanotechnology Market
World GDP ≈ $70 trillion
World Industry GDP ≈ $22 trillion Nano-enabled products ≈ $1 trillion
Nano products ≈ $17 billion
NanoTools ≈ $4 billion
The Business of Science®
Page 52 © Oxford Instruments 2013
• What fraction of the market is addressed by our products?
(Product coverage)
• What fraction of the customers can we reach?
(market Presence)
• What fraction of the customers choose us over the
competition?
(Hit rate)
Link to Oxford Instruments
PPH Analysis
The Business of Science®
Page 54 © Oxford Instruments 2013
Market Share
Market Share = 72% x 50% x 50% = 18%
The Business of Science®
Page 55 © Oxford Instruments 2013
• Increase R&D
spend
• Add technologies
through acquisitions
Nanotechnology Tools Sector PPH
- Product Coverage
0
5
10
15
20
25
30
2005/6 2006/7 2007/8 2008/9 2009/10 2010/11 2011/12
£M
The Business of Science®
Page 56 © Oxford Instruments 2013
• Increase direct presence
in BRIC
• Acquire distribution and
offer more Service
• Presence growth in
BRIC for acquisitions
Nanotechnology Tools Sector PPH
- Presence
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
2009 2010 2011 2012
£M
BRIC revenues
The Business of Science®
Page 57 © Oxford Instruments 2013
• Brand recognition value
• Recruit and retain best people
• Better, faster, more efficient internal
processes and controls
• Better integrated marcomms
• Better selling processes and CRM
• Improve customer satisfaction score
Nanotechnology Tools Sector PPH
- Hit Rate
The Business of Science®
Page 58 © Oxford Instruments 2013
100%
17%
71%
55%
7%
0%
20%
40%
60%
80%
100%
120%
Market Product Coverage
Presence Hit Rate Market Share
Nanotechnology Tools Sector PPH
The Business of Science®
Page 59 © Oxford Instruments 2013
Total Market
$4bn
Acquisition
Targets
Product Product Product Product
Presence Presence Presence Presence
Hit Rate Hit Rate Hit Rate Hit Rate
Plasma Tech
Market
Omicron
Market Hopper
NanoScience
Market NanoAnalysis
Market
Organic Growth
Strategy
R&D Plan
Sales Plan
Ops Plan
M&A
Strategy
Target
Selection
From Market to Strategy
NS NA
PT ON
Addressed Market
The Business of Science®
Page 60 © Oxford Instruments 2013
Techniques totalling $4.0bn
Market segmentation
The Business of Science®
Page 61 © Oxford Instruments 2013
Group Techniques into Clusters
Experimental equipment, $300M
Imaging, $1,600M
Characterisation, $600M
Nano-mechanics, $70M
Nano-structures, $1,100M
Nano-particles, $240M
0
10
20
30
40
50
60
70
80
90
100
Nu
mb
er
of
co
mp
an
ies
pa
rtic
ipa
tin
g
Market proximity
The Business of Science®
Page 62 © Oxford Instruments 2013
Market Concentration
OI
OI
OI
OI
OI
Co. 8
Co. 8 Co. 8
Co.8
Co. 7
Co. 7
Co. 7
Co. 6
Co. 5
Co. 5
Co. 5
Co. 4
Co. 3
Co. 3
Co. 3 Co. 2
Co. 2
Co. 2
Co. 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
experimental equipment
characterisation imaging nanomechanics nano structures/films particles
Sh
are
of
Clu
ste
r
The Business of Science®
Page 63 © Oxford Instruments 2013
Product Coverage
Characterisation Experimental
equipment Imaging Nano-structures Nano-mechanics Nano-particles
EBSD WDS EDS Technique C1 Technique C2 Technique C3 Technique C4 Technique C5 Technique C6 Technique C7 Technique C8 Technique C9
Cryogenics >1k ULT <1k Systems (MPHS/PMPS) Magnet Instrumentation (experiment control) Technique EE1 Technique EE2 Technique EE3
Technique I1 Technique I2 Technique I3 Technique I4 Technique I5 Technique I6 Technique I7 Technique I8
CVD PECVD PVD ALD RIE Technique NS1 Technique NS2 Technique NS3 Technique NS4 Technique NS5 Technique NS6 Technique NS7 Technique NS8
Technique NM1 Technique NM2 Technique NM3 Technique NM4 Technique NM5 Technique NM6 Technique NM7
Particle analysis Technique NP1 Technique NP2
Existing
The Business of Science®
Page 64 © Oxford Instruments 2013
Product Coverage
Omicron
Characterisation Experimental
equipment Imaging Nano-structures Nano-mechanics Nano-particles
EBSD WDS EDS XPS Auger Technique C3 Technique C4 Technique C5 Technique C6 Technique C7 Technique C8 Technique C9
Cryogenics >1k ULT <1k Systems (MPHS/PMPS) Magnet Instrumentation (experiment control) UHV Technique EE2 Technique EE3
SPM - UHV Technique I2 Technique I3 Technique I4 Technique I5 Technique I6 Technique I7 Technique I8
CVD PECVD PVD ALD RIE MBE Technique NS2 Technique NS3 Technique NS4 Technique NS5 Technique NS6 Technique NS7 Technique NS8
Technique NM1 Technique NM2 Technique NM3 Technique NM4 Technique NM5 Technique NM6 Technique NM7
Particle analysis Technique NP1 Technique NP2
Existing
The Business of Science®
Page 65 © Oxford Instruments 2013
Product Coverage
Omniprobe
Characterisation Experimental
equipment Imaging Nano-structures Nano-mechanics Nano-particles
EBSD WDS EDS XPS Auger Technique C3 Technique C4 Technique C5 Technique C6 Technique C7 Technique C8 Technique C9
Cryogenics >1k ULT <1k Systems (MPHS/PMPS) Magnet Instrumentation (experiment control) UHV Technique EE2 Technique EE3
SPM - UHV Technique I2 Technique I3 Technique I4 Technique I5 Technique I6 Technique I7 Technique I8
CVD PECVD PVD ALD RIE MBE Technique NS2 Technique NS3 Technique NS4 Technique NS5 Technique NS6 Technique NS7 Technique NS8
Nanomanipulators Technique NM2 Technique NM3 Technique NM4 Technique NM5 Technique NM6 Technique NM7
Particle analysis Technique NP1 Technique NP2
Omicron
Existing
The Business of Science®
Page 66 © Oxford Instruments 2013
Product Coverage
Asylum
Characterisation Experimental
equipment Imaging Nano-structures Nano-mechanics Nano-particles
EBSD WDS EDS XPS Auger Technique C3 Technique C4 Technique C5 Technique C6 Technique C7 Technique C8 Technique C9
Cryogenics >1k ULT <1k Systems (MPHS/PMPS) Magnet Instrumentation (experiment control) UHV Technique EE2 Technique EE3
SPM - UHV SPM - ambient Technique I3 Technique I4 Technique I5 Technique I6 Technique I7 Technique I8
CVD PECVD PVD ALD RIE MBE Technique NS2 Technique NS3 Technique NS4 Technique NS5 Technique NS6 Technique NS7 Technique NS8
Nanomanipulators NanoIndentation Technique NM3 Technique NM4 Technique NM5 Technique NM6 Technique NM7
Particle analysis Technique NP1 Technique NP2
Omniprobe
Omicron
Existing
The Business of Science®
Page 67 © Oxford Instruments 2013
Regular Reviews
Synergistic
targets Regular
Contact Negotiation
Due diligence
100 day plan
Contract Integration
Criteria: • Expand product coverage
• Leverage the brand
• Synergies in markets
• Technology proximity
• Cultural proximity
• Growth potential
• Margin potential in line with 14³
or better
• Geographical proximity
Criteria: • Shareholders ready
to sell
• Doable
• Can agree on price
Criteria: • Letter of intent
Criteria: • No deal breakers
• Acceptable contract
• Board approval
• Agreed 100 day plan
c.100
businesses
The M&A Funnel
The Business of Science®
Page 68 © Oxford Instruments 2013
Managing products, channels and
people
Ian Barkshire
Group Technical Director
The Business of Science®
Page 69 © Oxford Instruments 2013
Customers
& Markets
Market Intimacy & Voice of Customer
Select Product
Developments
Focused Product Development
Product
Launch & Customer
Support
Continuous Development Cycle
The Business of Science®
Page 70 © Oxford Instruments 2013
‘ICEBURG’ of
Available
Information
Superficial
Information
dig
dig
dig
NEEDS
summarise
dig
dig
dig
Market
Trends
summarise
Market Intimacy – Voice of Customer
• Exploration process
• Customer Interviews & Observations
• Global, Territory & Market Sector focus
The Business of Science®
Page 71 © Oxford Instruments 2013
Making NPI more effective
Planning Delivery Embed Execution
• FIVE Stage Gate Development Process
• Management Board sign off
• Audited process
The Business of Science®
Page 72 © Oxford Instruments 2013
Making NPI more effective
• FIVE Stage Gate Development Process
• Management Board sign off
• Audited process
Planning Delivery Embed Execution
The Business of Science®
Page 73 © Oxford Instruments 2013
Making NPI more effective
• FIVE Stage Gate Development Process
• Management Board sign off
• Audited process
Planning Delivery Execution
0
20
40
60
80
100
120
I F D L V
Cost
Flexibility
%
Gate
Embed
The Business of Science®
Page 74 © Oxford Instruments 2013
Making NPI more effective
0
20
40
60
80
100
120
I F D L V
Cost
Flexibility
%
Gate
• FIVE Stage Gate Development Process
• Management Board sign off
• Audited process
Planning Delivery Embed Execution
The Business of Science®
Page 75 © Oxford Instruments 2013
Making NPI more effective
• FIVE Stage Gate Development Process
• Management Board sign off
• Audited process
44% Vitality Index
Planning Delivery Embed Execution
The Business of Science®
Page 76 © Oxford Instruments 2013
SIZE Matters - Taking Analysis from hours to minutes
A real success story
150mm2
Aug 2012
The Business of Science®
Page 77 © Oxford Instruments 2013
What else Matters to Customers?
Thermal Stability
Throughput
Resolution
The Business of Science®
Page 80 © Oxford Instruments 2013
Finding & Riding the Waves
HB LED
Quantum Computing
The Business of Science®
Page 81 © Oxford Instruments 2013
Finding & Riding the Waves
HB LED
Graphene
Quantum Computing
The Business of Science®
Page 83 © Oxford Instruments 2013
Managing the people who make it happen
Outstanding Personal
Performance
Clear, inspiring strategy
Challenging work
Performance culture
Customer intimacy
Personal Recognition
Intelligent Dialogue
Technical Career Path
Ethical Values
The Business of Science®
Page 85 © Oxford Instruments 2013
Employee Engagement
• Understanding the strategy
• Emotional commitment
73%
35-40%
Benchmark
point
Oxford Instruments
The Business of Science®
Page 86 © Oxford Instruments 2013
Efficiencies
80.0
100.0
120.0
140.0
160.0
180.0
200.0
2005/06 2006/07 2007/08 2008/09 2009/10 2010/11 2011/12
£'0
00
Sales/employee
The Business of Science®
Page 87 © Oxford Instruments 2013
Managing & Integrating acquisitions
• Culture Advantage
• Engaging with Creative Staff
• Leverage ‘Value’ from proven OI processes
• Create new OI Champions
The Business of Science®
Page 88 © Oxford Instruments 2013
Summary and
Conclusions
Jonathan Flint
Chief Executive
The Business of Science®
Page 89 © Oxford Instruments 2013
• Nanotechnology is the place to be
• Broad exposure to Nanotechnology via Tools model
• Total Nanotechnology
• Tools market of $4bn
• PPH model drives detailed strategy
• Opportunity-rich, diverse market space
• People and processes to deliver growth
Summary
The Business of Science®
Page 90 © Oxford Instruments 2013
• This presentation concentrated on our
Nanotechnology Tools Sector
• Industrial Products Sector provides the opportunity
for industrialisation of Nanotech
• Service Sector provides stable, recurring revenues
to support R&D
Oxford Instruments Sectors
The Business of Science®
Page 91 © Oxford Instruments 2013
• 14 cubed target reaffirmed
• Strategic momentum for the medium and
long term, driven by successive
technology waves
• New strategic plan to be announced in
June 2014
Conclusions
The Business of Science®
Page 92 © Oxford Instruments 2013
Disclaimer
This presentation is prepared for and addressed to authorised persons within the meaning of the Financial Services and
Markets Act 2000 (FSMA). The information contained in this presentation is not for publication, distribution or reproduction,
in whole or in part, to any persons outside the jurisdiction of this Act. The Company, its Directors, employees, agents or
advisers do not accept or assume responsibility to any other person to whom this presentation is shown or into whose
hands it may come and any such responsibility or liability is expressly disclaimed.
Statements contained in this presentation are based on the knowledge and information available to the Company's
Directors at the date it was prepared and therefore the facts stated and views expressed may change after that date. By
their nature, any statements concerning the risks and uncertainties facing the Company in this presentation involve
uncertainty since future events and circumstances can cause results and developments to differ materially from those
anticipated. To the extent that this presentation contains any statement dealing with any time after the date of its
preparation such statement is merely predictive and speculative as it relates to events and circumstances which are yet to
occur. The Company undertakes no obligation to update these forward-looking statements.
The information in this presentation shall not constitute or be deemed to constitute any offer or invitation to invest in or
otherwise deal in shares or other securities of Oxford Instruments plc.
All information in the presentation is the property of Oxford Instruments plc.